MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakahata, N.
Right arrow Articles by Harden, T. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakahata, N.
Right arrow Articles by Harden, T. K.

H1-histamine receptors on human astrocytoma cells

N Nakahata, MW Martin, AR Hughes, JR Hepler and TK Harden

The H1-histamine receptor antagonist [3H]mepyramine bound with high affinity (Kd = 3-5 nM) to membranes derived from 1321N1 human astrocytoma cells. The H1-receptor antagonists triprolidine and diphenhydramine inhibited [3H]mepyramine binding with Kj values of 1-5 nM, whereas the Kj of the H2-histamine receptor antagonist cimetidine was greater than 100 microM. Histamine also inhibited [3H]mepyramine binding to 1321N1 cell membranes, and the histamine inhibition curve was shifted to the right and steepened in the presence of 1 microM guanosine 5'-O-(3-thiotriphosphate). Treatment of 1321N1 cells with pertussis toxin had no effect on the capacity of histamine to inhibit [3H]mepyramine binding either in the absence or presence of guanosine 5'-O-(3-thiotriphosphate). Therefore, agonist-occupied histamine receptors in these cells apparently interact with a guanine nucleotide regulatory protein that is not the inhibitory guanine nucleotide regulatory protein of adenylate cyclase. Although adenylate cyclase activity was not affected by histamine in a cell-free preparation, incubation of 1321N1 cells with histamine resulted in an attenuation of cyclic AMP accumulation. Analysis of cyclic AMP degradation in the presence of histamine indicated that the effects of histamine on cyclic AMP accumulation are mediated through activation of phosphodiesterase. This idea was supported by the fact that the phosphodiesterase inhibitor 1-isobutyl 3-methylxanthine blocked attenuation of cyclic AMP accumulation by histamine in a noncompetitive manner. Histamine also markedly increased phosphoinositide breakdown and 45Ca2+ efflux in 1321N1 cells. These histamine-induced effects apparently are mediated through H1-receptors, since triprolidine, but not cimetidine, potently inhibited histamine action. As for histamine interaction with its receptor, pertussis toxin had no effect on histamine-induced phosphoinositide breakdown, 45Ca2+ efflux, or attenuation of cyclic AMP accumulation. Taken together, these data indicate that 1321N1 human astrocytoma cells are a useful model system for the study of H1- histamine receptors and the biochemical responses mediated through these receptors.

Volume 29, Issue 2, pp. 188-195, 02/01/1986
Copyright © 1986 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
A. Strasser, B. Striegl, H.-J. Wittmann, and R. Seifert
Pharmacological Profile of Histaprodifens at Four Recombinant Histamine H1 Receptor Species Isoforms
J. Pharmacol. Exp. Ther., January 1, 2008; 324(1): 60 - 71.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. A. Goraya, N. Masada, A. Ciruela, and D. M. F. Cooper
Sustained Entry of Ca2+ Is Required to Activate Ca2+-Calmodulin-dependent Phosphodiesterase 1A
J. Biol. Chem., September 24, 2004; 279(39): 40494 - 40504.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. A. Drakulich, A. M. Walls, M. L. Toews, and T. D. Hexum
Neuropeptide Y Receptor-Mediated Sensitization of ATP-Stimulated Inositol Phosphate Formation
J. Pharmacol. Exp. Ther., November 1, 2003; 307(2): 559 - 565.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
W. B. Thoreson, J. S. Ryan, C. Shi, M. E. Kelly, E. J. Bryson, M. L. Toews, T. L. Ediger, and D. M. Chacko
Lysophosphatidic Acid Receptor Signaling in Mammalian Retinal Pigment Epithelial Cells
Invest. Ophthalmol. Vis. Sci., July 1, 2002; 43(7): 2450 - 2461.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Tang, I. H. Batty, and C. P. Downes
Muscarinic Receptors Mediate Phospholipase C-dependent Activation of Protein Kinase B via Ca2+, ErbB3, and Phosphoinositide 3-Kinase in 1321N1 Astrocytoma Cells
J. Biol. Chem., January 4, 2002; 277(1): 338 - 344.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
J. Wang, L. Wang, J. Zheng, J. L. Anderson, and M. L. Toews
Identification of Distinct Carboxyl-Terminal Domains Mediating Internalization and Down-Regulation of the Hamster alpha 1B- Adrenergic Receptor
Mol. Pharmacol., April 1, 2000; 57(4): 687 - 694.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
J. Wang, J. Zheng, J. L. Anderson, and M. L. Toews
A Mutation in the Hamster alpha 1B-Adrenergic Receptor that Differentiates Two Steps in the Pathway of Receptor Internalization
Mol. Pharmacol., August 1, 1997; 52(2): 306 - 313.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1986 by the American Society for Pharmacology and Experimental Therapeutics